Rchr
J-GLOBAL ID:201801020468534176   Update date: Aug. 25, 2020

Narikazu Boku

ボク ナリカズ | Narikazu Boku
Affiliation and department:
Papers (9):
more...
Lectures and oral presentations  (10):
  • 7. Randomizedphase II/III study of FLvs. FLTAX in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G
    (2019)
  • 6. Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G
    (ASCO-GI 2019)
  • 5. CT image features of peritoneal metastasis and outcomes of the advanced gastric cancer patients receiving 2nd line chemotherapy
    (ESMO-Asia 2018)
  • 4. Impact of adding ramucirumab to paclitaxel in patients with advanced gastric cancer according to the level of ascites
    (2018)
  • 3. Impact of ascites on the treatment of nivolumab for advanced gastric cancer patients
    (2018)
more...
Professional career (1):
  • 医学 (筑波大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page